ATE126706T1 - Hauttest und testkit für aids. - Google Patents

Hauttest und testkit für aids.

Info

Publication number: ATE126706T1
Authority: AT; Austria
Prior art keywords: test; aids; skin; kit; aids virus
Prior art date: 1988-11-21

Application number

AT89202922T

Other languages

English (en)

Inventor

Franklin Volvovitz

Original Assignee

Microgenesys Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-21

Filing date

1989-11-20

Publication date

1995-09-15

1989-11-20 Application filed by Microgenesys Inc filed Critical Microgenesys Inc

1995-09-15 Application granted granted Critical

1995-09-15 Publication of ATE126706T1 publication Critical patent/ATE126706T1/de

Links

208000030507 AIDS Diseases 0.000 title 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 2
108010003533 Viral Envelope Proteins Proteins 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000008961 swelling Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Immunology (AREA)
Dermatology (AREA)
Toxicology (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT89202922T 1988-11-21 1989-11-20 Hauttest und testkit für aids. ATE126706T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27419788A	1988-11-21	1988-11-21

Publications (1)

Publication Number	Publication Date
ATE126706T1 true ATE126706T1 (de)	1995-09-15

Family

ID=23047193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89202922T ATE126706T1 (de)	1988-11-21	1989-11-20	Hauttest und testkit für aids.

Country Status (14)

Country	Link
EP (1)	EP0370573B1 (de)
JP (1)	JPH02262527A (de)
KR (1)	KR900007384A (de)
CN (1)	CN1043081A (de)
AT (1)	ATE126706T1 (de)
AU (1)	AU630129B2 (de)
BR (1)	BR8905851A (de)
CA (1)	CA2003300A1 (de)
DE (1)	DE68923932T2 (de)
DK (1)	DK582689A (de)
IL (1)	IL92374A (de)
LV (1)	LV10203B (de)
NO (1)	NO894614L (de)
ZA (1)	ZA898833B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6224882B1 (en)	1997-11-07	2001-05-01	Protein Science Corp.	Insect cells or fractions as adjuvant for antigens
JP2006516883A (ja)	2002-09-19	2006-07-13	アメリカ合衆国	Ｐ．アリアシポリペプチド、ユウガイサシチョウバエポリペプチド、および使用法
MXPA05004714A (es)	2002-10-29	2006-03-17	Us Gov Health & Human Serv	Polipeptidos de lutzomyia longipalpis y metodos de uso.
EP2390352A1 (de)	2003-03-18	2011-11-30	Quantum Genetics Ireland Limited	Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren
US7468273B2 (en)	2003-05-01	2008-12-23	Meial Limited	Canine GHRH gene, polypeptides and methods of use
US20050214316A1 (en)	2003-11-13	2005-09-29	Brown Thomas P	Methods of characterizing infectious bursal disease virus
US20050202484A1 (en)	2004-02-19	2005-09-15	The Governors Of The University Of Alberta	Leptin promoter polymorphisms and uses thereof
HRP20100314T1 (hr)	2005-04-25	2010-08-31	Merial Ltd.	Cjepivo protiv nipah virusa
US20080241184A1 (en)	2005-08-25	2008-10-02	Jules Maarten Minke	Canine influenza vaccines
US7771995B2 (en)	2005-11-14	2010-08-10	Merial Limited	Plasmid encoding human BMP-7
JP2009515529A (ja)	2005-11-14	2009-04-16	メリアルリミテッド	腎不全のための遺伝子療法
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus
US8202967B2 (en)	2006-10-27	2012-06-19	Boehringer Ingelheim Vetmedica, Inc.	H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
EP2283035B1 (de)	2008-05-08	2015-07-29	Merial Limited	Leishmania impfstoff unter verwendung von sandmücken speichelimmunogen
MX2011010406A (es)	2009-04-03	2012-01-20	Merial Ltd	Vacunas aviares vectorizadas con el virus de la emfermedad de newcastle.
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP3156070A3 (de)	2010-08-31	2017-06-14	Merial Inc.	Auf das virus der newcastle-krankheit gerichtete herpesvirus-impfstoffe
AR083533A1 (es)	2010-10-22	2013-03-06	Boehringer Ingelheim Vetmed	Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
WO2012090073A2 (en)	2010-12-30	2012-07-05	The Netherlands Cancer Institute	Methods and compositions for predicting chemotherapy sensitivity
WO2012138789A2 (en)	2011-04-04	2012-10-11	Netherlands Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment
AU2012240240A1 (en)	2011-04-04	2013-05-09	Netherlands Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
WO2012145577A1 (en)	2011-04-20	2012-10-26	Merial Limited	Adjuvanted rabies vaccine with improved viscosity profile
EP2701736A1 (de)	2011-04-25	2014-03-05	Advanced Bioscience Laboratories, Inc.	Trunkierte hiv-hüllproteine (env), verfahren und zugehörige zusammensetzungen
CA2837375C (en)	2011-06-01	2019-07-16	Merial Limited	Needle-free administration of prrsv vaccines
EP2734230B1 (de)	2011-07-20	2018-11-21	Merial Limited	Rekombinante katzenleukämievirusvakzine die ein optimiertes gen des hüllproteins des katzenleukämievirus enthält
HUE035774T2 (en)	2011-08-12	2018-05-28	Merial Inc	Biological substances, in particular vaccines, preserved by vacuum
AR088028A1 (es)	2011-08-15	2014-05-07	Boehringer Ingelheim Vetmed	Proteinas h5, de h5n1 para un uso medicinal
WO2013033092A2 (en)	2011-09-03	2013-03-07	Boehringer Ingelheim Vetmedica Gmbh	Streptococcus suis pilus antigens
WO2013093629A2 (en)	2011-12-20	2013-06-27	Netherlands Cancer Institute	Modular vaccines, methods and compositions related thereto
WO2013138776A1 (en)	2012-03-16	2013-09-19	Merial Limited	Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
WO2013142371A1 (en)	2012-03-20	2013-09-26	Merial Limited	Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
MX360137B (es)	2013-02-21	2018-10-24	Boehringer Ingelheim Vetmedica Gmbh	Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento.
WO2014164697A1 (en)	2013-03-12	2014-10-09	Merial Limited	Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
KR20160132494A (ko)	2014-04-03	2016-11-18	베링거잉겔하임베트메디카인코퍼레이티드	돼지 유행성 설사 바이러스 백신
US10010499B2 (en)	2014-11-03	2018-07-03	Merial Inc.	Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
CA2990643C (en)	2015-06-23	2023-10-17	Merial, Inc.	Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
DK3344289T3 (da)	2015-08-31	2020-04-14	Boehringer Ingelheim Vetmedica Gmbh	Pestivirusvacciner mod medfødt tremor
CA2996613A1 (en)	2015-09-16	2017-03-23	Boehringer Ingelheim Vetmedica, Inc.	Salmonella choleraesuis-salmonella typhimurium vaccines
CA3036291A1 (en)	2016-09-20	2018-03-29	Boehringer Ingelheim Vetmedica Gmbh	New ehv insertion site orf70
BR112019005511A2 (pt)	2016-09-20	2019-10-01	Boehringer Ingelheim Vetmedica Gmbh	vetores de adenovírus canino
KR102543774B1 (ko)	2016-09-20	2023-06-19	베링거잉겔하임베트메디카게엠베하	신규한 프로모터
BR112019005415A2 (pt)	2016-09-20	2019-10-22	Boehringer Ingelheim Vetmedica Gmbh	nova vacina contra influenza suína
EP3534939B1 (de)	2016-11-03	2023-02-22	Boehringer Ingelheim Vetmedica GmbH	Impfstoff gegen das schweineparvovirus und das reproduktions- und atemwegsyndrom verursachende schweinevirus sowie herstellungsverfahren davon
EP4570264A3 (de)	2016-11-03	2026-01-21	Boehringer Ingelheim Vetmedica GmbH	Impfstoff gegen schweineparvovirus
AU2018212843A1 (en)	2017-01-30	2019-06-27	Boehringer Ingelheim Animal Health USA Inc.	Porcine coronavirus vaccines
US11179457B2 (en)	2017-07-12	2021-11-23	Boehringer Ingelheim Animal Health USA Inc.	Senecavirus a immunogenic compositions and methods thereof
CN111093698B (zh)	2017-09-23	2024-04-05	勃林格殷格翰动物保健有限公司	副粘病毒科表达系统
WO2019092027A1 (en)	2017-11-09	2019-05-16	Boehringer Ingelheim Vetmedica Gmbh	Sapelovirus immunogenic compositions and uses thereof
AU2019223768A1 (en)	2018-02-23	2020-08-27	Boehringer Ingelheim Animal Health USA Inc.	Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
CN111867637B (zh)	2018-03-19	2024-05-03	勃林格殷格翰动物保健有限公司	新ehv插入位点ul43
AR115002A1 (es)	2018-03-19	2020-11-18	Boehringer Ingelheim Vetmedica Gmbh	Ehv con ul18 y/o ul8 inactivados
KR102905685B1 (ko)	2018-03-26	2025-12-30	베링거 인겔하임 애니멀 헬스 유에스에이 인크.	면역원성 조성물의 제조방법
JP7284822B2 (ja)	2018-09-20	2023-05-31	ベーリンガーインゲルハイムフェトメディカゲーエムベーハー	改変ｐｅｄｖスパイクタンパク質
CN112867506B (zh)	2018-09-20	2025-08-05	勃林格殷格翰动物保健有限公司	抗猪流行性腹泻的鼻内载体疫苗
WO2021158878A1 (en)	2020-02-06	2021-08-12	Boehringer Ingelheim Animal Health USA Inc.	Polypeptides useful for detecting anti-rhabdovirus antibodies
KR20230082653A (ko)	2020-10-05	2023-06-08	베링거잉겔하임베트메디카게엠베하	로타바이러스에 대한 백신 접종에 유용한 융합 단백질
US20220160864A1 (en)	2020-10-05	2022-05-26	Boehringer Ingelheim Animal Health USA Inc.	Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8422513D0 (en) *	1984-09-06	1984-10-10	Wellcome Found	Immunodiagnostic methods
US4879212A (en) *	1986-04-02	1989-11-07	United Biomedical Inc.	Peptide composition and method for the detection of antibodies to HTLV-III
IL84154A0 (en) *	1986-10-16	1988-03-31	Microgenesys Inc	Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
JPS63258575A (ja) *	1986-12-15	1988-10-26	レプリゲン　コーポレーション	昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク
EP0279688B1 (de) *	1987-02-20	1997-04-16	Genentech, Inc.	Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern
WO1989006276A2 (en) *	1988-01-08	1989-07-13	Dpz Deutsches Primatenzentrum Gesellschaft Mbh	Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions

1989
- 1989-11-17 CA CA002003300A patent/CA2003300A1/en not_active Abandoned
- 1989-11-20 ZA ZA898833A patent/ZA898833B/xx unknown
- 1989-11-20 DK DK582689A patent/DK582689A/da not_active Application Discontinuation
- 1989-11-20 AT AT89202922T patent/ATE126706T1/de not_active IP Right Cessation
- 1989-11-20 EP EP89202922A patent/EP0370573B1/de not_active Expired - Lifetime
- 1989-11-20 DE DE68923932T patent/DE68923932T2/de not_active Expired - Fee Related
- 1989-11-20 AU AU45335/89A patent/AU630129B2/en not_active Ceased
- 1989-11-20 NO NO89894614A patent/NO894614L/no unknown
- 1989-11-20 JP JP1303048A patent/JPH02262527A/ja active Pending
- 1989-11-20 IL IL9237489A patent/IL92374A/en not_active IP Right Cessation
- 1989-11-20 KR KR1019890016798A patent/KR900007384A/ko not_active Withdrawn
- 1989-11-21 CN CN89109558A patent/CN1043081A/zh active Pending
- 1989-11-21 BR BR898905851A patent/BR8905851A/pt not_active Application Discontinuation
1993
- 1993-06-30 LV LVP-93-877A patent/LV10203B/xx unknown

Also Published As

Publication number	Publication date
CA2003300A1 (en)	1990-05-21
DK582689A (da)	1990-05-22
LV10203A (lv)	1994-10-20
NO894614D0 (no)	1989-11-20
BR8905851A (pt)	1990-06-12
AU630129B2 (en)	1992-10-22
EP0370573A2 (de)	1990-05-30
JPH02262527A (ja)	1990-10-25
KR900007384A (ko)	1990-06-01
DE68923932D1 (de)	1995-09-28
EP0370573B1 (de)	1995-08-23
DK582689D0 (da)	1989-11-20
CN1043081A (zh)	1990-06-20
ZA898833B (en)	1990-08-29
EP0370573A3 (de)	1991-08-14
LV10203B (en)	1995-04-20
NO894614L (no)	1990-05-22
IL92374A0 (en)	1990-07-26
DE68923932T2 (de)	1996-01-11
AU4533589A (en)	1990-05-24
IL92374A (en)	1994-02-27

Legal Events

Date	Code	Title	Description
1997-02-15	REN	Ceased due to non-payment of the annual fee
1997-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE126706T1 (de)	1995-09-15	Hauttest und testkit für aids.
ATE127345T1 (de)	1995-09-15	Stressproteine und verwendungen dafür.
ATE229978T1 (de)	2003-01-15	Helicobacter proteine und impstoffe
DE68929323D1 (de)	2001-10-18	Pneumolysin-mutanten und pneumokokken-impfstoffe daraus
DE68929551D1 (de)	2007-05-10	Menschliche DNase
DK0526544T3 (da)	1999-06-21	Terapeutiske anvendelser af actinbindende forbindelser
NO890496D0 (no)	1989-02-07	Fremgangsmaate og anordning for ikke-inntrengende akustisk undersoekelse av elastisiteten til mykt, biologisk vev.
ATE294864T1 (de)	2005-05-15	Äusseres membranprotein von haemophilus
DK0957935T3 (da)	2003-06-23	Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
DE69628844D1 (de)	2003-07-31	Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
DE68911975D1 (de)	1994-02-17	Ophthalmoskopisches Diagnoseverfahren und Gerät.
DK0909323T3 (da)	2007-05-21	Helicobacter pylori-bakterioferritin
FI884823A7 (fi)	1988-10-19	Virusantigeeni, sen valmistusmenetelmä ja käyttö diagnoosissa ja hoido ssa
FI920356A0 (fi)	1992-01-27	En biologisk preparation samt dess anvaendning.
FI881122L (fi)	1988-09-14	Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
PT636030E (pt)	2004-05-31	Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
FI885025A0 (fi)	1988-11-01	Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
FI973335A0 (fi)	1997-08-14	Helicobacter pylori-antigeeni
SE8002898L (sv)	1980-10-19	Biologiskt aktiv substans och forfarande for framstellning derav
NO905619L (no)	1991-02-26	Identifikasjon av humane t-lymfocyttepitoper i patogener for vaksineutvikling.
IT8665506A0 (it)	1986-08-29	Autoiniettore automatico per rapidissime inoculazioni intramuscolare o sottocutanee disoluzioni e/o principi attivi sterili per uso profilattico immediato.